Please assess the completion status of the following clinical trial:

Trial Title: Safety, and Immunogenicity of Two Influenza Vaccines in Healthy Subjects 3 to 64 Years Old

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy subjects 3 to 64 years of age~Exclusion Criteria:~* Receipt of other investigational products within 3 months or other vacine within 1 month;~* Allergy to eggs, egg products, or any other vaccine component;~* Laboratory confirmed influenza disease within 6 months;~* Have previously received an influenza vaccination (3 to 8 years only);

- Gender: ALL
- Minimum Age: 3 Years
- Maximum Age: 64 Years
- Healthy Volunteers: t

Study Arms:
- Influenza virus vaccine (Type: EXPERIMENTAL): None
- Comparator influenza vaccine (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).